Biochemical Characterization of the Active Anti-Hepatitis C Virus Metabolites of 2,6-Diaminopurine Ribonucleoside Prodrug Compared to Sofosbuvir and BMS-986094

Ribonucleoside analog inhibitors (rNAI) target the hepatitis C virus (HCV) RNA-dependent RNA polymerase nonstructural protein 5B (NS5B) and cause RNA chain termination. Here, we expand our studies on β-d-2′-C-methyl-2,6-diaminopurine-ribonucleotide (DAPN) phosphoramidate prodrug 1 (PD1) as a novel i...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Main Authors: Ehteshami, Maryam, Tao, Sijia, Ozturk, Tugba, Zhou, Longhu, Cho, Jong Hyun, Zhang, Hongwang, Amiralaei, Sheida, Shelton, Jadd R., Lu, Xiao, Khalil, Ahmed, Domaoal, Robert A., Stanton, Richard A., Suesserman, Justin E., Lin, Biing, Lee, Sam S., Amblard, Franck, Whitaker, Tony, Coats, Steven J., Schinazi, Raymond F.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2016
Assuntos:
Antiviral Agents
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4958185/
https://ncbi.nlm.nih.gov/pubmed/27216050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00318-16
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares